Bloodstream infection testing market size wasย $5.17 billion in 2021, and is estimated to reach $10.54 billion by 2030, growing at a CAGR of 8.3% from 2022 to 2030.
Blood stream infection is a condition where any bacterial, fungal or any type of infection is detected in the blood. The condition is evident when the infection enters into the blood stream of any part of the body. The bacteria or organisms that causes the blood infection are determined by using blood stream infection testing.ย Increasing incidences of bloodstream infection in elderly population who are susceptible to infection due to low immunity is anticipated to drive the global bloodstream infection testing market demand and boost revenue growth of the market. The initiatives of various organizations to spread awareness regarding transfusion-transmitted infections is also expected to boost the market growth.ย High demand for technologically advanced diagnostic tests, awareness about hygiene, diagnosis rate, and unhealthy lifestyle are also expected to fuel the market growth over the forecast period.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
The major players in the global bloodstream infection testing market are Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Abbott, BD, BIOMรRIEUX, Cepheid, Luminex Corporation, Accelerate Diagnostics Inc., AdvanDX, and Bruker.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/3934
According to the recent data by United Nations, as of July 2022, the global population has reached 7.96 billion. This rising population is predicted to fuel revenue growth of the blood stream infection testing market. According to the Centers for Disease Control and Prevention (CDC), patients with infections in the urinary tract, kidney, lung, and abdominal area are prone to suffer from Blood Stream Infection. In addition, people who are suffering with HIV or receiving chemotherapy treatment are at a higher risk of developing BSI. It is one of the serious complications for patients who are admitted in critical care units. This infection not only lengthens the hospital stay, but also increases chances of life-threatening comorbidities and sometimes leads to death.
The global bloodstream infection testing market is segmented based on product, technique, technology, application, end-user, and region. By product, the market is sub-segmented into instruments, consumables, and software & services. By technique, the market is sub-segmented into conventional and automated. By technology, the market is sub-segmented into culture-based, molecular, and proteomic. By application, the market is sub-segmented into bacterial, fungal, and mycobacterial. By end-user, the market is sub-segmented into hospitals, independent diagnostics centers, and others. By region, the market is sub-segmented into North America, Europe, Asia-Pacific, and LAMEA.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/3934
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- Based on product, the consumables sub-segment is predicted hold the maximum market share and also to be the fastest growing sub-segment
- Based on technique, the conventional sub-segment is predicted to hold the maximum market share and the automated sub-segment is expected to grow with the highest CAGR over the forecast period
- Based on technology, the culture-based sub-segment is predicted to have a high market share throughout the analysis period and the molecular sub-segment is predicted to grow at the highest CAGR in the estimated timeframe
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.